Session IV. Ethical, liability and regulatory issues
In the present climate, the exposure to litigation is great for vaccine programs, in general, and for any perinatal event--even in the absence of real injury. [...]it must be acknowledged that giving vaccines to pregnant women will expose the system to litigation. With the slim profit margin attaine...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2003-07, Vol.21 (24), p.3501-3502 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3502 |
|---|---|
| container_issue | 24 |
| container_start_page | 3501 |
| container_title | Vaccine |
| container_volume | 21 |
| creator | Glezen, W.Paul |
| description | In the present climate, the exposure to litigation is great for vaccine programs, in general, and for any perinatal event--even in the absence of real injury. [...]it must be acknowledged that giving vaccines to pregnant women will expose the system to litigation. With the slim profit margin attained by vaccine production, it is unlikely that manufacturers will be willing to produce vaccines for administration to pregnant women even if they are proven to be safe. [...]the only possibility for progress will be the extension of programs like the US Vaccine Injury Compensation Program to cover vaccines recommended for delivery to pregnant women [8]. |
| doi_str_mv | 10.1016/S0264-410X(03)00398-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73463129</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X03003980</els_id><sourcerecordid>3379144261</sourcerecordid><originalsourceid>FETCH-LOGICAL-c334t-4e70679150d9c315c53dfebd2ef7a656f8d66deaebc06046b01ded972c1c2e953</originalsourceid><addsrcrecordid>eNqF0M9r2zAUwHExWpY025-wYRgtK9Tpk_XD1qmU0LWFwg5py25Clp43BcduJbuQ_35KE1bYpSfp8NHT40vIFwpzClSeL6GQPOcUfn0HdgrAVJXDBzKlVcnyQtDqgEz_kQk5inEFAIJR9ZFMaFEJYFJNCV9ijL7vstvHeXY1_PHWtGdZ603tWz9sMtO5LODvsTVDHzaZj3HE-IkcNqaN-Hl_zsjDj6v7xU1-9_P6dnF5l1vG-JBzLEGWigpwyjIqrGCuwdoV2JRGCtlUTkqHBmsLErisgTp0qiwstQUqwWbkZDf3KfTP6d9Br3202Lamw36MumRcMlqoBL_9B1f9GLq0m6aCSylLVvGkxE7Z0McYsNFPwa9N2GgKehtVv0bV22IamH6Nmi4z8nU_fazX6N5e7SsmcLwHJqZ-TTCd9fHNcaVUGp_cxc5hivbiMehoPXYWnQ9oB-16_84qfwFdZpHq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1546667384</pqid></control><display><type>article</type><title>Session IV. Ethical, liability and regulatory issues</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Glezen, W.Paul</creator><creatorcontrib>Glezen, W.Paul</creatorcontrib><description>In the present climate, the exposure to litigation is great for vaccine programs, in general, and for any perinatal event--even in the absence of real injury. [...]it must be acknowledged that giving vaccines to pregnant women will expose the system to litigation. With the slim profit margin attained by vaccine production, it is unlikely that manufacturers will be willing to produce vaccines for administration to pregnant women even if they are proven to be safe. [...]the only possibility for progress will be the extension of programs like the US Vaccine Injury Compensation Program to cover vaccines recommended for delivery to pregnant women [8].</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/S0264-410X(03)00398-0</identifier><identifier>PMID: 12850369</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Biological and medical sciences ; Female ; Humans ; Immunization ; Infant, Newborn ; Influenza ; Liability, Legal ; Litigation ; Medical sciences ; Patient Acceptance of Health Care ; Pregnancy ; Prenatal Care ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Teaching. Deontology. Ethics. Legislation ; Vaccination - ethics ; Vaccination - legislation & jurisprudence ; Vaccines ; Womens health</subject><ispartof>Vaccine, 2003-07, Vol.21 (24), p.3501-3502</ispartof><rights>2003 Elsevier Science Ltd</rights><rights>2003 INIST-CNRS</rights><rights>Copyright Elsevier Limited Jul 28, 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c334t-4e70679150d9c315c53dfebd2ef7a656f8d66deaebc06046b01ded972c1c2e953</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0264410X03003980$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,23909,23910,25118,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14999016$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12850369$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Glezen, W.Paul</creatorcontrib><title>Session IV. Ethical, liability and regulatory issues</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>In the present climate, the exposure to litigation is great for vaccine programs, in general, and for any perinatal event--even in the absence of real injury. [...]it must be acknowledged that giving vaccines to pregnant women will expose the system to litigation. With the slim profit margin attained by vaccine production, it is unlikely that manufacturers will be willing to produce vaccines for administration to pregnant women even if they are proven to be safe. [...]the only possibility for progress will be the extension of programs like the US Vaccine Injury Compensation Program to cover vaccines recommended for delivery to pregnant women [8].</description><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Humans</subject><subject>Immunization</subject><subject>Infant, Newborn</subject><subject>Influenza</subject><subject>Liability, Legal</subject><subject>Litigation</subject><subject>Medical sciences</subject><subject>Patient Acceptance of Health Care</subject><subject>Pregnancy</subject><subject>Prenatal Care</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Teaching. Deontology. Ethics. Legislation</subject><subject>Vaccination - ethics</subject><subject>Vaccination - legislation & jurisprudence</subject><subject>Vaccines</subject><subject>Womens health</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqF0M9r2zAUwHExWpY025-wYRgtK9Tpk_XD1qmU0LWFwg5py25Clp43BcduJbuQ_35KE1bYpSfp8NHT40vIFwpzClSeL6GQPOcUfn0HdgrAVJXDBzKlVcnyQtDqgEz_kQk5inEFAIJR9ZFMaFEJYFJNCV9ijL7vstvHeXY1_PHWtGdZ603tWz9sMtO5LODvsTVDHzaZj3HE-IkcNqaN-Hl_zsjDj6v7xU1-9_P6dnF5l1vG-JBzLEGWigpwyjIqrGCuwdoV2JRGCtlUTkqHBmsLErisgTp0qiwstQUqwWbkZDf3KfTP6d9Br3202Lamw36MumRcMlqoBL_9B1f9GLq0m6aCSylLVvGkxE7Z0McYsNFPwa9N2GgKehtVv0bV22IamH6Nmi4z8nU_fazX6N5e7SsmcLwHJqZ-TTCd9fHNcaVUGp_cxc5hivbiMehoPXYWnQ9oB-16_84qfwFdZpHq</recordid><startdate>20030728</startdate><enddate>20030728</enddate><creator>Glezen, W.Paul</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20030728</creationdate><title>Session IV. Ethical, liability and regulatory issues</title><author>Glezen, W.Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c334t-4e70679150d9c315c53dfebd2ef7a656f8d66deaebc06046b01ded972c1c2e953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Humans</topic><topic>Immunization</topic><topic>Infant, Newborn</topic><topic>Influenza</topic><topic>Liability, Legal</topic><topic>Litigation</topic><topic>Medical sciences</topic><topic>Patient Acceptance of Health Care</topic><topic>Pregnancy</topic><topic>Prenatal Care</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Teaching. Deontology. Ethics. Legislation</topic><topic>Vaccination - ethics</topic><topic>Vaccination - legislation & jurisprudence</topic><topic>Vaccines</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Glezen, W.Paul</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Glezen, W.Paul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Session IV. Ethical, liability and regulatory issues</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2003-07-28</date><risdate>2003</risdate><volume>21</volume><issue>24</issue><spage>3501</spage><epage>3502</epage><pages>3501-3502</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>In the present climate, the exposure to litigation is great for vaccine programs, in general, and for any perinatal event--even in the absence of real injury. [...]it must be acknowledged that giving vaccines to pregnant women will expose the system to litigation. With the slim profit margin attained by vaccine production, it is unlikely that manufacturers will be willing to produce vaccines for administration to pregnant women even if they are proven to be safe. [...]the only possibility for progress will be the extension of programs like the US Vaccine Injury Compensation Program to cover vaccines recommended for delivery to pregnant women [8].</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>12850369</pmid><doi>10.1016/S0264-410X(03)00398-0</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2003-07, Vol.21 (24), p.3501-3502 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73463129 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Biological and medical sciences Female Humans Immunization Infant, Newborn Influenza Liability, Legal Litigation Medical sciences Patient Acceptance of Health Care Pregnancy Prenatal Care Public health. Hygiene Public health. Hygiene-occupational medicine Teaching. Deontology. Ethics. Legislation Vaccination - ethics Vaccination - legislation & jurisprudence Vaccines Womens health |
| title | Session IV. Ethical, liability and regulatory issues |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T15%3A04%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Session%20IV.%20Ethical,%20liability%20and%20regulatory%20issues&rft.jtitle=Vaccine&rft.au=Glezen,%20W.Paul&rft.date=2003-07-28&rft.volume=21&rft.issue=24&rft.spage=3501&rft.epage=3502&rft.pages=3501-3502&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/S0264-410X(03)00398-0&rft_dat=%3Cproquest_cross%3E3379144261%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1546667384&rft_id=info:pmid/12850369&rft_els_id=S0264410X03003980&rfr_iscdi=true |